Stereotaxis’s magnetically steerable radiofrequency guidewire is said to be designed to ablate through chronic total occlusions (CTO) in peripheral arteries. Its Niobe magnetic navigation system directs the guidewire’s
Ms Pero will lead the expansion of the Global Alliance for TB Drug Development’s (TB Alliance) staff and internal operations as it advances the new tuberculosis (TB) drug
The companies have signed an agreement that enables Medrad to sell CADstream in the UK, Germany and Italy. Under the agreement, Confirma will install, train and support all
Similar to the 385K and 4x72K NimbleGen microarrays, the new 12x135K arrays display high specificity, high sensitivity, and excellent reproducibility, the company said. For researchers interested in studying
The Named Patient Access Program (NPAP) is a compassionate use drug supply program under which medical practitioners can legally supply investigational drugs to their eligible patients. Under this
Under the grant, Maxygen will continue development of ParallelaVax technology for rapid generation of vaccine candidates and high-throughput testing in animal models. The work will be done in
The waiver applies to all 14 drugs that the company currently tests for in addition to two different cut-off levels for its opiate and cocaine tests. Clinical Laboratory
This is said to be the third Oradur-based opioid drug candidate covered by Durect’s collaboration with Pain Therapeutics, for which King Pharmaceuticals holds the commercialization rights. Pain Therapeutics
Under the terms of NIR Diagnostics’s settlement with Masimo, as with the Shaklee-Masimo settlement that preceded it, the case has been dismissed without either party incurring financial liability
Greyson intends to enter the royalty division of business and effectively license Trilexon to clients in the drug, cosmetic and toiletry industries, upon which Greyson will retain a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.